MDxHealth SA (MDXH) vs Exagen Inc. (XGN)
MDxHealth SA and Exagen Inc. are both Diagnostics & Research companies. Exagen Inc. is the larger, with a market value of $233.3M against $55.5M — 4.2× the size. MDxHealth SA grew revenue faster over the last twelve months: 21.5% against 20.8%. Exagen Inc. has the higher net margin (−26.6% vs −32.5%) and the lower return on invested capital (−68.3% vs −23.8%). Across the 17 metrics below, MDxHealth SA leads on 13 and Exagen Inc. on 4.
Valuation
Profitability
| Metric | MDXH | XGN | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 63.23% | 58.64% | 50.89% |
| Operating margin | (18.04%) | (18.58%) | (8.57%) |
| Net margin | (32.53%) | (26.61%) | (6.37%) |
| Free cash flow margin | (5.24%) | (10.66%) | 0.00% |
| Return on equity | 238.67% | (113.82%) | (2.92%) |
| Return on assets | (27.38%) | (34.19%) | (6.71%) |
| Return on invested capital | (23.77%) | (68.33%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack